Toggle menu

SALI Study

Start date:
August 2016
End date:
December 2019
Co-ordinated by:
Julia Grahamslaw
Main trial site:
Royal Infirmary of Edinburgh

Aim

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Trial Design

Longitudinal prospective cohort questionnaire study

Eligibility criteria

Patients of 18 yrs and older, with isolated ankle injuries, who meet the Ottawa Ankle Rules positive (OAR+) criteria (Buffalo modification), but are negative for a significant ankle fracture on subsequent x-ray, will be included in the study.

Local PI

Professor Alasdair Gray

Honorary Professor of Emergency Medicine & Clinical Director of the Emergency Department

Research Team

Julia Grahamslaw

Lead Research Nurse

Caroline Blackstock

AMU Senior Research Nurse

Dr Adam Lloyd

Honorary Research Fellow & Lecturer

Alison Williams

Senior Research Nurse

Claire Cheyne

Research Nurse- Bank Staff

More EMERGE Trials

DASH Trial

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

Read more

SABER Study

Developing a molecular tool to stratify the acute joint presentation: facilitating early diagnosis of septic arthritis (Septic Arthritis Biomarker Emergency Rule-out - SABER)

EHA - Epidemiological analysis for the Hereditary Angioedema Disease is an international, multicentre, epidemiological study that aims to explore the feasibility of a new Dried Blood Spot (DBS) filtercard-based screening algorithm and thereby the prevalence of the Hereditary Angioedema.

Read more

EHA Study

EHA - Epidemiological analysis for the Hereditary Angioedema Disease